June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
UV-Cross-Linked Hyaluronic Acid as Vitreous Substitute - OCT, histological and immunohistochemical results 12 months after implantation
Author Affiliations & Notes
  • Martin Stephan Spitzer
    Ophthalmology, Tuebingen University Eye Center, Tuebingen, Germany
  • Charlotte Schramm
    Ophthalmology, Tuebingen University Eye Center, Tuebingen, Germany
  • Tomek Mlynczak Mlynczak
    Ophthalmology, Tuebingen University Eye Center, Tuebingen, Germany
  • Peter Szurman
    Ophthalmology, Tuebingen University Eye Center, Tuebingen, Germany
  • Sven Schnichels
    Ophthalmology, Tuebingen University Eye Center, Tuebingen, Germany
  • Kai Januschowski
    Ophthalmology, Tuebingen University Eye Center, Tuebingen, Germany
  • Footnotes
    Commercial Relationships Martin Spitzer, Clanotech (C), Croma Pharma (F), Novartis (F); Charlotte Schramm, None; Tomek Mlynczak, None; Peter Szurman, None; Sven Schnichels, Croma Pharma (F), Novartis (F); Kai Januschowski, Croma Pharma (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5108. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Martin Stephan Spitzer, Charlotte Schramm, Tomek Mlynczak Mlynczak, Peter Szurman, Sven Schnichels, Kai Januschowski; UV-Cross-Linked Hyaluronic Acid as Vitreous Substitute - OCT, histological and immunohistochemical results 12 months after implantation. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5108.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Recently we had shown that UV-cross-linked hyaluronic acid biopolymers may be suitable as vitreous replacement and stay for up to 9 months within in the vitreous cavity. Here we present the histological and OCT results after 12 months of implantation.

Methods: The vitreous was removed by pars plana vitrectomy in rabbit eyes and replaced by injection of the UV-cross-linked biogels. In each case the right eye was operated on and the left eye served as the control. ERG, slit lamp examination, funduscopy, OCT volume scans and measurement of intraocular pressure were performed at regular intervals postoperatively. The eyes were enucleated 12 months after surgery, histology and immunohistochemistry for CD4, CD20, CD45 and CD68 was performed.<br />

Results: Retinal thickness and retinal architecture on OCT was unaltered during the entire follow-up when compared to the unoperated fellow eye. Histology (H&E and PAS stain) confirmed the intact retinal structure after 12 months. There were no foreign body reactions. No remnants of the hydrogels could be detected in the vitreous cavity after 12 months. On immunohistochemistry no increased number of lymphocytes or mononuclear cells could be detected in the choroid, retina or the vitreous cavity compared to control.

Conclusions: The results confirm the potential and the long-term biocompatibility of cross-linked hyaluronic acid biopolymers as a long-term vitreous replacement. The hydrogel dissolves completely 12 months after surgery.<br />

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×